Clinical Gastroenterology and Hepatology
Volume 8, Issue 3 , Pages 235-244 , March 2010

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis

  • Marjolein Sikkema

      Affiliations

    • Department of Gastroenterology and Hepatology, Erasmus MC – University Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationReprint requests Address requests for reprints to: Marjolein Sikkema, MD, Department of Gastroenterology and Hepatology, Erasmus MC – University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands. fax: (31) 10-7032793
    • ,
  • Pieter J.F. de Jonge

      Affiliations

    • Department of Gastroenterology and Hepatology, Erasmus MC – University Medical Center, Rotterdam, The Netherlands
    • ,
  • Ewout W. Steyerberg

      Affiliations

    • Department of Public Health, Erasmus MC – University Medical Center, Rotterdam, The Netherlands
    • ,
  • Ernst J. Kuipers

      Affiliations

    • Department of Gastroenterology and Hepatology, Erasmus MC – University Medical Center, Rotterdam, The Netherlands
    • Department of Internal Medicine, Erasmus MC – University Medical Center, Rotterdam, The Netherlands

Full Text Available

  • Purchase this article for  31.50 USD

    Access is available for 24 hours.

    (Login or Register to purchase)

  • Subscribe to this title
  • Claim access now

    Current subscribers


    •  This article has an accompanying continuing medical education activity on page e32. Learning Objectives—At the end of this activity, the learner should recognize the low risk of esophageal adenocarcinoma in Barrett's esophagus and appreciate that no randomized trials have compared surveillance to a no surveillance strategy.

     Conflict of interest The authors disclose no conflicts.

    PII: S1542-3565(09)01045-3

    doi: 10.1016/j.cgh.2009.10.010

    Clinical Gastroenterology and Hepatology
    Volume 8, Issue 3 , Pages 235-244 , March 2010